COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,363 Articles (22,803 medRxiv, 8,560 bioRxiv)

Most recent first Previous |  Page 2537: Articles 25361-25370  | Next

A translational multiplex serology approach to profile the prevalence of anti-SARS-CoV-2 antibodies in home-sampled blood
Roxhed, N., Bendes, A., Dale, M., Mattsson, C., Hanke, L., Dodig-Crnkovic, T., Christian, M., Meineke, B., Elsasser, S., Andrell, J., Haverall, S., Thalin, C., Eklund, C., Dillner, J., Beck, O., Thomas, C. E., McInerney, G., Hong, M.-G., Murrell, B., Fredolini, C., Schwenk, J. M.
10.1101/2020.07.01.20143966 — Posted: 2020-07-02 Discussion: Onsite
If the link missed：Could inflammatory skin disorders with barrier dysfunction increase the risk of COVID-19?
Xu, Q., Chen, L., Zhang, L., Li, X., Zheng, J.
10.1101/2020.06.30.181297 — Posted: 2020-07-01
Early data on the performance of a combined SARS-CoV-2 spike-nucleocapsid antibody lateral flow device compared to a nucleocapsid-only device
Linares, C. A., Ryan, F., Moses, S. E.
10.1101/2020.07.01.182618 — Posted: 2020-07-01
Genetic architecture of host proteins interacting with SARS-CoV-2
Pietzner, M., Wheeler, E., Carrasco-Zanini, J., Raffler, J., Kerrison, N. D., Oerton, E., Auyeung, V. P. W., Luan, J., Finan, C., Casas, J. P., Ostroff, R., Williams, S. A., Kastenmüller, G., Ralser, M., Gamazon, E. G., Wareham, N. J., Hingorani, A. D., Langenberg, C.
10.1101/2020.07.01.182709 — Posted: 2020-07-01
Genetic analysis of SARS-CoV-2 strains collected from North Africa: viral origins and mutational spectrum
Laamarti, M., Kartti, S., Alouane, T., Laamarti, R., Allam, L., Ouadghiri, M., Chemao-Elfihri, M. W., Smyej, I., Rahoui, J., Benrahma, H., Diawara, I., Essabbar, A., Boumajdi, N., Bendani, H., Bouricha, E. M., Aanniz, T., El Attar, J., El Hafidi, N., El Jaoudi, R., Sbabou, L., Nejjari, C., Amzazi, S., Mentag, R., Belyamani, L., Ibrahimi, A.
10.1101/2020.06.30.181123 — Posted: 2020-07-01
Fourier spectral density of the coronavirus genome
Tan, H. S.
10.1101/2020.06.30.180034 — Posted: 2020-07-01
Identification of peptide candidate against COVID-19 through reverse vaccinology: An immunoinformatics approach
Das, R. P., Jagadeb, M., Rath, S. N.
10.1101/2020.07.01.150805 — Posted: 2020-07-01 Discussion: Onsite
Next-generation diagnostics: virus capture facilitates a sensitive viral diagnosis for epizootic and zoonotic pathogens including SARS-CoV-2
Wylezich, C., Calvelage, S., Schlottau, K., Ziegler, U., Pohlmann, A., Hoeper, D., Beer, M.
10.1101/2020.06.30.181446 — Posted: 2020-07-01
High affinity binding of SARS-CoV-2 spike protein enhances ACE2 carboxypeptidase activity
Lu, J., Sun, P. D.
10.1101/2020.07.01.182659 — Posted: 2020-07-01
periscope: sub-genomic RNA identification in SARS-CoV-2 ARTIC Network Nanopore Sequencing Data
Parker, M. D., Lindsey, B. B., Leary, S., Gaudieri, S., Chopra, A., Wyles, M., Angyal, A., Green, L. R., Parsons, P., Tucker, R. M., Brown, R., Groves, D., Johnson, K., Carrilero, L., Heffer, J., Partridge, D., Evans, C., Razza, M., Keeley, A. J., Smith, N., Wang, D., Mallal, S., de Silva, T. I.
10.1101/2020.07.01.181867 — Posted: 2020-07-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).